This is mediated in part through oncogenic signaling networks such as the PI3K-AKT-mTOR pathway, which is commonly deregulated in human prostate cancer [7], and has been shown to direct the translation of distinct groups of mRNAs, modulating their protein expression without altering their transcript levels [5, 8]. This evidence concerns the gene MTOR and prostate cancer.